These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21675134)

  • 1. [Clinical effectiveness and costs of antibiotics in respiratory infections].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2011 May; 30(179):327-9. PubMed ID: 21675134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic pharmacoeconomics].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2008 Nov; 25(149):437-8. PubMed ID: 19177784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economics of antibiotic use policies.
    Paladino JA
    Pharmacotherapy; 2004 Dec; 24(12 Pt 2):232S-8S. PubMed ID: 15585453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW; Pettit KG; Arnold RJ; Kaniecki DJ
    Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotics in primary care].
    Steciwko A; Lubieniecka M; Muszyńska A
    Pol Merkur Lekarski; 2011 May; 30(179):323-6. PubMed ID: 21675133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic usage for respiratory tract infections in an era of rising resistance and increased cost pressure.
    Spiritus E
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1216-21. PubMed ID: 11187446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
    Simoens S; Decramer M; Laekeman G
    Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute infections of the upper respiratory tract--factors that contribute to diagnosis and antibiotic prescription decisions].
    Vranjes Z; Katić V; Vinter-Repalust N; Jurković L; Tiljak H; Cerovecki-Nekić V; Simunović R; Petric D; Katić M
    Acta Med Croatica; 2007 Feb; 61(1):83-90. PubMed ID: 17593646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The choice of antimicrobial therapy by application of pharmacoeconomic principles in view of the most frequently isolated pathogens at the Clinic for Infectious Diseases of the Clinical Center of Vojvodina].
    Stefan-Mikić S; Sević S; Jovanović N; Cvjetković D; Aleksić-Dordević M
    Med Pregl; 2010; 63 Suppl 1():52-9. PubMed ID: 21438205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excessive antibiotic use for acute respiratory infections in the United States.
    Gonzales R; Malone DC; Maselli JH; Sande MA
    Clin Infect Dis; 2001 Sep; 33(6):757-62. PubMed ID: 11512079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods.
    Gonzales R; Bartlett JG; Besser RE; Cooper RJ; Hickner JM; Hoffman JR; Sande MA
    Ann Emerg Med; 2001 Jun; 37(6):690-7. PubMed ID: 11385342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational use of antibiotics to treat respiratory tract infections.
    File TM; Hadley JA
    Am J Manag Care; 2002 Aug; 8(8):713-27. PubMed ID: 12212759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing the benefits and costs of antibiotic drugs: the TREAT model.
    Leibovici L; Paul M; Andreassen S
    Clin Microbiol Infect; 2010 Dec; 16(12):1736-9. PubMed ID: 20673259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory tract infections: diagnosis and use of antibiotics by family physicians in north-eastern Poland.
    Chlabicz S; Małgorzata-Ołtarzewska A; Pytel-Krolczuk B
    Int J Antimicrob Agents; 2004 May; 23(5):446-50. PubMed ID: 15120721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of oral antibiotic therapy.
    Nightingale CH; Quintiliani R
    Pharmacotherapy; 1997; 17(2):302-7. PubMed ID: 9085322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
    Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
    Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phamacoeconomic analysis of antibiotics use in the Clinical Center of Vojvodina].
    Stefan-Mikić S; Jovanović J; Jovanović N; Aleksić-Dordević M; Cvjetković D; Krajcir I
    Med Pregl; 2008; 61 Suppl 1():50-8. PubMed ID: 19248640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.